Incorporation of functional imaging data in the evaluation of dose distributions using the generalized concept of equivalent uniform dose

Physics in Medicine and Biology

Volumn 49, Issue 9, 2004, Pages 1711-1721

  Miften, Moyed M ^a   Das, Shiva K ^a   Su, Min ^a   Marks, Lawrence B ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; DATA REDUCTION; LIGHT EMISSION; PHOTONS; RADIOTHERAPY; TUMORS;

EQUIVALENT UNIFORM DOSE (EUD); FUNCTIONAL IMAGING;

MEDICAL IMAGING;

FLUORODEOXYGLUCOSE;

ARTICLE; BEAM THERAPY; CALCULATION; CLONOGENESIS; DATA ANALYSIS; EVALUATION; HISTOGRAM; IMAGING SYSTEM; INTENSITY MODULATED RADIATION THERAPY; LUNG NON SMALL CELL CANCER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT PLANNING;

CARCINOMA, NON-SMALL-CELL LUNG; EVALUATION STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PHOTONS; RADIATION ONCOLOGY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RELATIVE BIOLOGICAL EFFECTIVENESS; SKIN;

EID: 2542490460     PISSN: 00319155     EISSN: None     Source Type: Journal    
DOI: 10.1088/0031-9155/49/9/009     Document Type: Article

References (54)

1. Alber M, Paulsen F, Eschmann S M and Machulla H J 2003 On biologically conformal boost dose optimization Phys. Med. Biol. 48 N31-5
2. Albes J M et al 2002 Value of positron emission tomography for lung cancer staging Eur. J. Surg. Oncol. 28 55-62
3. Avril N et al 2001 Glucose metabolism of breast cancer assessed by F-18-FDG PET: histologic and immunohistochemical tissue analysis J. Nucl. Med. 42 9-16
4. Batho H F 1964 Lung corrections in cobalt 50 beam therapy J. Can. Assoc. Radiol. 15 79
5. Berlangieri S U et al 1999 F-18 fluorodeoxyglucose positron emission tomography in the non-invasive staging of non-small cell lung cancer Eur. J. Cardiothorac. Surg. 16 S25-30
6. Boersma L J, Damen E M, de Boer R W, Muller S H, Valdes Olmos R V, Hoefnagel C A, Roos C M, van Zandwijk N and Lebesque J V 1993 A new method to determine dose-effect relations for local lung-function changes using correlated SPECT and CT data Radiother. Oncol. 29 110-6
7. Bos R el al 2002 Biologic correlates of (18) fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography J. Clini. Oncol. 20 379-87
8. Bria W F, Kanarek D J and Kazemi H 1983 Prediction of post-operative pulmonary function following thoracic operations J. Thorac. Cardivasc. Surg. 86 186-92
9. Buck A et al 2002 FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters Eur. J. Nucl. Med. Mol. Imaging 29 1317-23
10. Burman C et al 1991 Fitting of normal tissue tolerance data to an analytic function Int. J. Radiat. Oncol. Biol. Phys. 21 123-35
11. Chang S X, Cullip T J, Rosenman J G, Halvorsen P H and Tepper J E 2002 Dose optimization via index-dose gradient minimization Med. Phys. 29 1130-42
12. Chin J et al 2002 Whole body FDG-PET for the evaluation and staging of small cell lung cancer: a preliminary study Lung Cancer 37 1-6
13. Choi N C et al 2002 Dose-response relationship between probability of pathologic tumour control and glucose metabolic rate measured with FDG PET after preoperative chemoradiotherapy in locally advanced non-small-cell lung cancer Int. J. Radiat. Oncol. Biol. Phys. 54 1024-35
14. Das S, Miften M, Zhou S, Bell M, Munley M, Whiddon C, Craciunescu O, Baydush A, Wong T, Rosenman J, Dewhirst M and Marks L 2003 Dosimetric feasibility of fluorine-18-fluorodeoxyglucose positron emission tomography and single photon emission computed tomography guided dose delivery in lung tumours Med. Phys. accepted
15. Dhital K et al 2000 [18F]Fluorodeoxyglucose positron emission tomography and its prognostic value in lung cancer Eur. J. Cardiothorac. Surg. 18 425-8
16. Dimitrakopoulou-Strauss A et al 2001 Dynamic PET F-18-FDG studies in patients with primary and recurrent soft-tissue sarcomas: impact on diagnosis and correlation with grading J. Nucl. Med. 42 713-20
17. Eary J F et al 2002 Sarcoma tumour FDG uptake measured by PET and patient outcome: a retrospective analysis Eur. J. Nucl. Med. Mole. Imaging 29 1149-54
18. Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider J E, Shan B, Solin L J and Wesson A M 1991 Tolerance of normal tissue to therapeutic irradiation Int. J. Radiat. Oncol. Biol. Phys. 21 109-22
19. Halfpenny W et al 2002 FDG-PET. A possible prognostic factor in head and neck cancer Br. J. Cancer 86 512-6
20. Higsashi K et al 2000 FDG PET measurement of the proliferative potential of non-small cell lung cancer J. Nucl. Med 41 85-92
21. Jacob R et al 2001 Fluorine-18 fluorodeoxyglucose positron emission tomography, DNA ploidy and growth fraction in squamous-cell carcinomas of the head and neck ORl-J. Otorhinolaryngol. Relat. Spec. 63 307-13
22. Jeong H J et al 2002 Determination of the prognostic value of F-18 fluorodeoxyglucose uptake by using positron emission tomography in patients with non-small cell lung cancer Nucl. Med. Commun. 23 865-70
23. Kole A C et al 1999 FDG and L-1-C-11-tyrosine imaging of soft-tissue tumours before and after therapy J. Nucl. Med. 40 381-6
24. Kristersson S, Lindel S E and Svanberg L 1972 Prediction of pulmonary function loss due to penumonectomy using Xe-radiospirometry Chest 62 694-8
25. Kutcher G J and Burman C 1989 Calculation of complication probability factors for non-uniform normal tissue radiation: The effective volume method Int. J. Radiat. Oncol. Biol. Phys. 16 1623-30
26. Kutcher G J et al 1991 Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations Int. J. Radiat. Oncol. Biol. Phys. 21 137-46
27. Lu Y, Spelbring R and Chen G T Y 1997 Functional dose-volume histograms for functionally heterogeneous normal organs Phys. Med. Biol. 42 345-56
28. Lyman J T and Wolbarst A B 1987 Optimization of radiation therapy:III. A method of assessing complication probabilities from dose-volume histograms Int. J. Radiat. Oncol. Biol. Phys. 13 103-9
29. Marks L B, Spencer D P, Bentel G C, Ray S K, Sherouse G W, Sontag M R, Coleman R E, Jaszczak R J and Turkington T G 1993 The utility of SPECT lung perfusion scans in minimizing and assessing the physiologic consequences of thoracic irradiation Int. J. Radiat. Oncol. Biol. Phys. 26 659-68
30. Marks L B, Spencer D P, Sherouse G W, Bentel G, Clough R, Vann K, Jaszczak R, Coleman R E and Prosnitz L P 1995 The role of three-dimensional functional lung imaging in radiation treatment planning: The functional dose-volume histogram Int. J. Radiat. Oncol. Biol. Phys. 33 65-75
31. Marks L B, Munley M T, Spencer D P, Sherouse G W, Bentel G C, Hoppenworh J, Chew M, Jaszczak R J, Coleman R E and Prosnitz L 1997 Quantification of radiation-induced regional lung injury with perfusion imaging Int. J. Radiat. Oncol. Biol. Phys. 38 399-409
32. Marks L B, Sherouse G W, Munley M T, Bentel G C and Spencer D P 1999 Incorporation of functional status into dose-volume analysis Med. Phys. 26 196-9
33. Mohan R et al 1992 Clinically relevant optimization of 3D conformal treatments Med. Phys. 19 933-44
34. Nerini-Molteni S et al 2001 Uptake of tritiated thymidine, deoxyglucose and methionine in three lung cancer cell lines: deoxyglucose uptake mirrors tritiated thymidine uptake Tumor Biol. 22 92-6
35. Niemierko A 1997 Reporting and analyzing dose distributions: a concept of equivalent uniform dose Med. Phys. 24 103-10
36. Niemierko A 1999 A generalized concept of equivalent uniform dose (EUD) Med. Phys. 26 1100 (abstract)
37. Osborne D et al 1982 In vivo regional quantification of intrathoracic TC-99m using SPECT: concise communication J. Nucl. Med. 23 446-50
38. Osborne D et al 1985 SPECT quantification of TC-99m microspheres within the canine lung J. Assist. Tomogr. 9 73-7
39. Oyama N et al 2002 Prognostic value of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography imaging for patients with prostate cancer Mole. Imaging Biol. 4 99-104
40. Pugsley J M et al 2002 The Ki-67 index and survival in non-small cell lung cancer: a review and relevance to positron emission tomography Cancer J. 8 222-33
41. Saunders C B et al 1999 Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer Ann. Thorac. Surg. 67 790-7
42. Seppenwoolde Y, Engelsman M, De Jaeger K, Muller S H, Baas P, McShan D L, Fraass B A, Kessler M L, Belderbos J S A, Boersma L J and Lebesque J V 2002 Optimizing radiation treatment plans for lung cancer using lung perfusion information Radiother. Oncol. 63 165-77
43. Shiomi S et al 2001 Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose for predicting outcome in patients with hepatocellular carcinoma Am. J. Gastroenterol. 96 1877-80
44. Shon I H et al 2002 Positron emission tomography in lung cancer Semi. Nucl. Med. 32 240-71
45. Smith T A D and Titley J 2000 Deoxyglucose uptake by a head and neck squamous carcinoma: Influence of changes in proliferative fraction Int. J. Radiat. Oncol. Biol. Phys. 47 219-23
46. Sontag M R and Cunningham J R 1978 The equivalent tissue-air ratio for making absorbed dose calculations in a heterogeneous medium Radiology 129 787-94
47. Staverv P, Staverva N, Niemierko A and Goitein M 2001 Generalization of a model of tissue response to radiation based on the idea of functional subunits and binomial statistics Phys. Med. Biol. 46 1501-18
48. Theuws J C M, Kwa S L S, Wagenaar A C, Seppenwoolde Y, Boersma L J, Damen E M F, Muller S H, Baas P and Lebesque J V 1999 Prediction of overall pulmonary function loss in relation to the 3-D dose distribution for patients with breast cancer and malignant lymphoma 233-43 49
49. Vesselle H et al 2000 Lung cancer proliferation correlates with F-18 fluorodeoxyglucose uptake by positron emission tomography Clin. Cancer Res. 6 3837-44
50. Wernley J A et al 1980 Clinical value of quantitative ventilation-perfusion lung scans in the surgical management of bronchogenic carcinoma J. Thorac. Cardiovasc. 80 535-43
51. Wong R J et al 2002 Diagnostic and prognostic value of F-18 fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma J. Clin. Oncol. 20 4199-208
52. Wu Q, Mohan R, Niemierko A and Schmidt-Ullrich R 2002 Optimization of intensity-modulated radiotherapy plans based on the equivalent uniform dose Int. J. Radiat. Oncol. Biol. Phys. 52 224-35
53. Xing L, Cotrutz C, Hunja S, Boyer A L, Adalsteinsson E and Spielman D 2002 Inverse planning for functional and image-guided intensity-modulated radiation therapy Phys. Med. Biol. 47 3567-78
54. Yorke E D, Kutcher G J, Jackson A and Ling C C 1993 Probability of radiation-induced complications in normal tissues with parallel architecture under conditions of uniform whole or partial organ irradiation Radiother. Oncol. 26 226-37